Quest Diagnostics Inc (DGX) Stock Price, Quote & News

Company Profile

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians...

Industry: Diagnostics & Research

Sector: Healthcare

Phone: 973 520 2700

Website: www.questdiagnostics.com

Address:

500 Plaza Drive, Secaucus, United States

ZacksResearch Jun. 17 at 1:17 PM

$DGX teams up with MD Anderson — why this matters for cancer diagnostics 🎯 Since announcing the collaboration, Quest Diagnostics shares rose 2.6%, amid positive market sentiment regarding the partnership. With only 51% of U.S. adults undergoing routine screenings, the future test aims to supplement conventional methods. Discover the full potential here 👉 https://www.zacks.com/commentary/2506147/dgx-stock-up-on-new-blood-test-development-deal-with-md-anderson?cid=sm-stocktwits-2-2506147-body&ADID=SYND_STOCKTWITS_TWEET_2_2506147_BODY

0 · Reply

ZacksResearch Jun. 17 at 11:42 AM

New cancer test collab sends $DGX higher — here's why it matters 🧬📈 Quest is teaming up with MD Anderson to develop a blood test aimed at detecting multiple cancer risks — a potential game-changer in early detection. Full story on the partnership 👉 https://www.zacks.com/stock/news/2506147/dgx-stock-up-on-new-blood-test-development-deal-with-md-anderson?cid=sm-stocktwits-2-2506147-teaser&ADID=SYND_STOCKTWITS_TWEET_2_2506147_TEASER

0 · Reply

Small_time_trader Jun. 16 at 6:50 PM

$DGX Too hot for the hot tub

0 · Reply

JarvisFlow Jun. 13 at 6:59 PM

Mizuho updates rating for Quest Diagnostics ( $DGX ) to Outperform, target set at 174 → 177.

0 · Reply

BottomFishingCharts Jun. 10 at 4:40 PM

🇺🇸 $DGXX | 🇨🇦 $DGX has virtually ZERO resistance right up to $2.85 #BottomFishing 📉📈

1 · Reply

BottomFishingCharts Jun. 9 at 9:20 PM

🇺🇸 $DGXX | 🇨🇦 $DGX.. I ran across this #BitcoinMining play this afternoon and when I checked the chart I scooped a starter and told the #BottomFishing 📉📈 Team about it in our Private Discord... Chart setups like this one beg attention.. Pop 'n top over the 21 day EMA followed by a sustained pop 'n top over the 50, followed by a crossover confirmation, followed by a pop 'n stick over the 200 are definitely attention getters... Include a momentum / sentiment oscillator that's powering up and over the 50% level and one just can't resist to throw a few morsels of bait at it... Add a ripping #Bitcoin topping 109K and it's smoothie time...

3 · Reply

ZacksResearch May. 27 at 12:58 PM

$HOLX vs. $DGX — Which healthcare stock should you hold? 🤔 🌟 Hologic shines with diversified growth drivers and financial strength, but faces macro challenges. 💡 Quest Diagnostics boasts strong growth in Women's Health, buoyed by recent acquisitions and AI initiatives. Explore the full analysis here 👉 https://www.zacks.com/commentary/2477533/holx-vs-dgx-which-womens-health-focused-stock-is-the-better-pick?cid=sm-stocktwits-2-2477533-body&ADID=SYND_STOCKTWITS_TWEET_2_2477533_BODY

1 · Reply

ZacksResearch May. 27 at 11:27 AM

The women's health market is booming, with $HOLX and $DGX leading the charge. But which one stands out more for investors today? Explore more: https://www.zacks.com/stock/news/2477533/holx-vs-dgx-which-womens-health-focused-stock-is-the-better-pick?cid=sm-stocktwits-2-2477533-teaser&ADID=SYND_STOCKTWITS_TWEET_2_2477533_TEASER

0 · Reply

ZacksResearch May. 21 at 2:04 PM

$DGX has shown notable strength in the past year, driven by robust core performance and contributions from acquisitions. Read more: https://www.zacks.com/stock/news/2475104/whats-driving-quest-diagnostics-stocks-256-rally-in-a-year?cid=sm-stocktwits-2-2475104-teaser&ADID=SYND_STOCKTWITS_TWEET_2_2475104_TEASER

0 · Reply

theresilienttrader May. 15 at 3:08 PM

$DGX 🧪 $DGX | Bullish Setup Alert Quest Diagnostics just raised its dividend 💰 and posted 12% revenue growth. Low EV/Sales. High margins. A base forming on the chart. We’re long DGX and selling puts for income. 🎯 Target: $190 → $210 💡 Strategy: Buy + sell June $165 puts (~$1.75 premium) 📈 A resilient long hiding in plain sight. Full trade breakdown here: https://www.theresilienttrader.com/p/quest-diagnostics-dgx

0 · Reply

Quest Diagnostics to Develop Multi-cancer Stratification (MCaST) Blood Test Based on MD Anderson Technology

May 20, 2025, 8:52 AM EDT - 4 weeks ago

More Americans Know Their Streaming Platform Passwords by Heart Than Their Cholesterol Score, New Survey Reveals

May 16, 2025, 1:11 PM EDT - 5 weeks ago

Quest Diagnostics to Speak at the William Blair 45th Annual Growth Stock Conference

May 14, 2025, 6:17 PM EDT - 5 weeks ago

Quest Diagnostics Declares Quarterly Cash Dividend

May 13, 2025, 6:03 AM EDT - 5 weeks ago

Oncologists Report Seeing More Advanced Cancers and Say Current Tests Are Not Catching Cancer Recurrence Early Enough, New Quest Diagnostics Report Finds

May 3, 2025, 4:26 AM EDT - 7 weeks ago

Quest Diagnostics: A Leader But Waiting For Better Price

Apr 23, 2025, 1:17 PM EDT - 2 months ago

These Analysts Boost Their Forecasts On Quest Diagnostics After Better-Than-Expected Q1 Earnings

Apr 22, 2025, 12:09 PM EDT - 2 months ago

Quest Diagnostics Revenue Rebound, Strategic Moves Fuel Outlook Confidence

Apr 22, 2025, 11:39 AM EDT - 2 months ago

Quest Diagnostics Incorporated (DGX) Q1 2025 Earnings Call Transcript

Apr 22, 2025, 7:37 AM EDT - 2 months ago

Quest beats quarterly profit estimates on strong demand for diagnostic tests

Apr 22, 2025, 7:01 AM EDT - 2 months ago

Quest Diagnostics earnings beat after March rebound in demand from slump early in the quarter

Apr 22, 2025, 6:43 AM EDT - 2 months ago

Quest Diagnostics Reports First Quarter 2025 Financial Results; Reaffirms Revenue and Adjusted Diluted EPS Guidance for Full Year 2025

Apr 9, 2025, 7:53 AM EDT - 2 months ago

Quest Diagnostics Launches New AD-Detect™ Blood Test to Aid in Confirming Alzheimer's Disease

Apr 4, 2025, 1:43 PM EDT - 2 months ago

8 Upcoming Dividend Increases During Volatile Times

AMT BKU GD KAI ORCL REIT RNP

Apr 2, 2025, 7:06 AM EDT - 2 months ago

Quest Diagnostics Introduces HPV Specimen Self-Collection for Cervical Cancer Screening

Apr 1, 2025, 4:23 PM EDT - 2 months ago

Quest Diagnostics to Release First Quarter 2025 Financial Results on April 22, 2025

Mar 19, 2025, 7:52 AM EDT - 3 months ago

Quest Diagnostics to Highlight Strategic Priorities to Drive Sustainable Growth and Deliver Long-term Shareholder Value at 2025 Investor Day

Mar 18, 2025, 9:00 AM EDT - 3 months ago

Quest Diagnostics to Collaborate with Google Cloud to Streamline Data and Personalize Customer Experiences Using Generative AI

Feb 24, 2025, 8:00 AM EST - 4 months ago

Fresenius Medical Care Announces Divestment of Select Laboratory Assets to Quest Diagnostics

FMS

Feb 13, 2025, 4:54 PM EST - 4 months ago

Quest Diagnostics to Host Investor Day on March 19, 2025

Feb 12, 2025, 9:00 AM EST - 4 months ago

GRAIL and Quest Diagnostics Provide GRAIL's Galleri® Multi-Cancer Early Detection (MCED) Test Through the Quest Diagnostics Test Ordering System

GRAL

Jan 30, 2025, 4:14 PM EST - 5 months ago

Quest Diagnostics Named to Fortune's World's Most Admired Companies List for 11th Consecutive Year

Jan 30, 2025, 2:35 PM EST - 5 months ago

Quest Diagnostics Incorporated (DGX) Q4 2024 Earnings Call Transcript

Jan 30, 2025, 6:45 AM EST - 5 months ago

Quest Diagnostics Reports Fourth Quarter and Full Year 2024 Financial Results; Provides Guidance for Full Year 2025; Increases Quarterly Dividend 6.7% to $0.80 Per Share

Jan 27, 2025, 8:56 AM EST - 5 months ago

Quest Diagnostics Completes Acquisition of the Outreach Lab Services Business of University Hospitals

Jan 8, 2025, 8:42 AM EST - 5 months ago

Quest Diagnostics Names Adrienne Brott Senior Vice President and Chief Quality and Regulatory Affairs Officer

Jan 2, 2025, 11:00 AM EST - 6 months ago

Quest Diagnostics to Release Fourth Quarter and Full Year 2024 Financial Results on January 30, 2025

Dec 3, 2024, 9:50 AM EST - 7 months ago

Quest Diagnostics to Speak at the 7th Annual Evercore HealthCONx Conference

Dec 3, 2024, 8:23 AM EST - 7 months ago

Quest Diagnostics Launches Health Coaching on questhealth.com to Help Individuals Take Control of Their Health

Nov 25, 2024, 10:44 AM EST - 7 months ago

15 stocks — including Palantir and Nvidia — whose sales estimates have risen the most this earnings season

NVDA PLTR APH ATO BLK CNC CTRA

Nov 15, 2024, 1:05 PM EST - 7 months ago

Augurex Life Sciences and Quest Diagnostics Collaborate to Improve Rheumatoid Arthritis Diagnosis and Management

Oct 24, 2024, 10:10 AM EDT - 8 months ago

Quest Diagnostics Has Massive Secular Tailwinds And A Strong Base

Oct 24, 2024, 8:36 AM EDT - 8 months ago

Quest Diagnostics: Organic Growth Leads To Q3 Earnings Beat

Oct 23, 2024, 8:08 AM EDT - 8 months ago

US lab operator Quest Diagnostics to launch bird flu test at end of October

Oct 23, 2024, 7:53 AM EDT - 8 months ago

Quest Diagnostics Awarded CDC Contracts for H5 Avian Influenza and Oropouche Virus Test Development

Oct 22, 2024, 4:57 PM EDT - 8 months ago

Overlooked Stock: DGX

Oct 22, 2024, 11:40 AM EDT - 8 months ago

Quest Diagnostics (DGX) Q3 2024 Earnings Call Transcript

Oct 22, 2024, 11:08 AM EDT - 8 months ago

Quest Diagnostics CEO Touts 'New Customer Wins' In Q3, Expects Earnings Growth In 2025

Oct 22, 2024, 8:05 AM EDT - 8 months ago

Quest Diagnostics beats quarterly results estimates on diagnostic test demand

Oct 22, 2024, 6:45 AM EDT - 8 months ago

Quest Diagnostics Reports Third Quarter 2024 Financial Results; Updates Guidance for Full Year 2024

Oct 15, 2024, 8:04 AM EDT - 8 months ago

Quest Diagnostics Introduces Specimen Self-Collection for Common Genital Tract Infection Testing at Nationwide Network of Patient Service Centers

Oct 15, 2024, 3:28 AM EDT - 8 months ago

Quest Diagnostics: The Better Half Of An Emerging Healthcare Duopoly

Oct 14, 2024, 8:50 AM EDT - 8 months ago

Quest Diagnostics Completes Acquisition of Lab Assets from OhioHealth

Sep 25, 2024, 11:24 AM EDT - 9 months ago

Quest Diagnostics to Release Third Quarter 2024 Financial Results on October 22, 2024

Sep 18, 2024, 8:51 AM EDT - 9 months ago

Sentara Health Plans and Quest Diagnostics Form Strategic Collaboration to Extend Lab Access in Parts of the Southeast

Sep 16, 2024, 8:51 AM EDT - 9 months ago

Quest Diagnostics Completes Acquisition of Select Lab Assets from Allina Health

Aug 28, 2024, 3:31 PM EDT - 10 months ago

Quest Diagnostics to Speak at the Morgan Stanley 22nd Annual Global Healthcare Conference

Aug 26, 2024, 8:50 AM EDT - 10 months ago

Quest Diagnostics Completes Acquisition of LifeLabs, Enhancing Access to Diagnostic Innovation

Aug 21, 2024, 8:55 AM EDT - 10 months ago

Quest Diagnostics to Acquire University Hospitals' Outreach Laboratory Services Business

Aug 15, 2024, 6:13 PM EDT - 11 months ago

Quest Diagnostics Prices $1.85 Billion of Senior Notes

ZacksResearch Jun. 17 at 1:17 PM

0 · Reply

ZacksResearch Jun. 17 at 11:42 AM

0 · Reply

Small_time_trader Jun. 16 at 6:50 PM

$DGX Too hot for the hot tub

0 · Reply

JarvisFlow Jun. 13 at 6:59 PM

Mizuho updates rating for Quest Diagnostics ( $DGX ) to Outperform, target set at 174 → 177.

0 · Reply

BottomFishingCharts Jun. 10 at 4:40 PM

🇺🇸 $DGXX | 🇨🇦 $DGX has virtually ZERO resistance right up to $2.85 #BottomFishing 📉📈

1 · Reply

BottomFishingCharts Jun. 9 at 9:20 PM

3 · Reply

ZacksResearch May. 27 at 12:58 PM

1 · Reply

ZacksResearch May. 27 at 11:27 AM

0 · Reply

ZacksResearch May. 21 at 2:04 PM

0 · Reply

theresilienttrader May. 15 at 3:08 PM

0 · Reply

ZacksResearch May. 13 at 12:09 PM

$DGX continues to stay on investors' radars due to its robust Advanced Diagnostics offerings and strength in acquisitions. Learn more: https://www.zacks.com/stock/news/2467650/should-you-continue-to-retain-dgx-stock-in-your-portfolio?cid=sm-stocktwits-2-2467650-teaser&ADID=SYND_STOCKTWITS_TWEET_2_2467650_TEASER

0 · Reply

Estimize May. 12 at 12:15 PM

Wall St is expecting 2.57 EPS for $DGX Q2 [Reporting 07/23 BMO] http://www.estimize.com/intro/dgx?chart=historical&metric_name=eps&utm_cont

0 · Reply

Armonica423 May. 10 at 10:12 PM

$DGX Big exposure for CYDY at 3 oncology conferences this coming week, do your dd research

0 · Reply

Kascnef82 May. 8 at 7:54 PM

$DGX https://downdetector.com/status/quest-diagnostics/

0 · Reply

GreatDaneTrader May. 7 at 7:24 PM

$DGX $INBS https://www.biomedwire.com/intelligent-bio-solutions-inc-nasdaq-inbs-is-one-to-watch/ Quicker, cheeper, less invasive drug test, and the company is only valued at 8M$ compared to DGX who is valued at 20B$. for 80K you can own 1% of the company who have the world best drug test, what is there to think about?

0 · Reply

Estimize May. 7 at 1:09 PM

Wall St is expecting 2.57 EPS for $DGX Q2 [Reporting 07/23 BMO] http://www.estimize.com/intro/dgx?chart=historical&metric_name=eps&utm_cont

0 · Reply

JarvisFlow May. 6 at 12:00 PM

JP Morgan updates rating for Quest Diagnostics ( $DGX ) to Neutral, target set at 180 → 190.

0 · Reply

Small_time_trader Apr. 29 at 5:22 PM

$DGX Hold, baby hold

0 · Reply

JarvisFlow Apr. 28 at 4:51 PM

Piper Sandler updates rating for Quest Diagnostics ( $DGX ) to Neutral, target set at 180 → 200.

0 · Reply

JFDI Apr. 25 at 12:38 AM

$DGX massive base

0 · Reply

JarvisFlow Apr. 23 at 4:45 PM

Truist Securities updates rating for Quest Diagnostics ( $DGX ) to Hold, target set at 182 → 190.

0 · Reply

JarvisFlow Apr. 23 at 1:05 PM

Barclays updates rating for Quest Diagnostics ( $DGX ) to Equal-Weight, target set at 175 → 185.

0 · Reply

Market Cap	20.03B
Revenue (ttm)	9.87B
Net Income (ttm)	871.00M
EPS (ttm)	N/A
PE Ratio	19.74
Forward PE	18.50
Profit Margin	8.82%
Debt to Equity Ratio	0.84

Volume	1,016,700
Avg Vol	1,201,006
Day's Range	N/A - N/A
Shares Out	111.64M
Stochastic %K	70%
Beta	0.49
Analysts	Strong Sell
Price Target	$186.59